Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    June 2019
  1. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    Correction: The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2019 Jun 13. pii: 10.1038/s41388-019-0838.
    PubMed     Text format     Abstract available


    May 2019
  2. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2019 May 8. pii: 10.1038/s41388-019-0753.
    PubMed     Text format     Abstract available


  3. SORIA-VALLES C, Gutierrez-Fernandez A, Guiu M, Mari B, et al
    Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
    Oncogene. 2019 May 3. pii: 10.1038/s41388-019-0825.
    PubMed     Text format     Abstract available


  4. GUNARATNA RT, Santos A, Luo L, Nagi C, et al
    Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Oncogene. 2019;38:3535-3550.
    PubMed     Text format     Abstract available


    April 2019
  5. YANG RM, Nanayakkara D, Kalimutho M, Mitra P, et al
    MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.
    Oncogene. 2019 Apr 10. pii: 10.1038/s41388-019-0789.
    PubMed     Text format     Abstract available


  6. TAN BS, Yang MC, Singh S, Chou YC, et al
    LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0812.
    PubMed     Text format     Abstract available


  7. HE M, Jin Q, Chen C, Liu Y, et al
    The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0817.
    PubMed     Text format     Abstract available


  8. YOSHINO Y, Qi H, Kanazawa R, Sugamata M, et al
    RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.
    Oncogene. 2019;38:3077-3092.
    PubMed     Text format     Abstract available


  9. GOMES AM, Carron EC, Mills KL, Dow AM, et al
    Stromal Gas6 promotes the progression of premalignant mammary cells.
    Oncogene. 2019;38:2437-2450.
    PubMed     Text format     Abstract available


    March 2019
  10. KARADEDOU CT, Gomes AR, Chen J, Petkovic M, et al
    Correction: FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Oncogene. 2019 Mar 13. pii: 10.1038/s41388-019-0770.
    PubMed     Text format     Abstract available


  11. GOODING AJ, Zhang B, Gunawardane L, Beard A, et al
    The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Oncogene. 2019;38:2020-2041.
    PubMed     Text format     Abstract available


  12. MARQUES M, Jangal M, Wang LC, Kazanets A, et al
    Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Oncogene. 2019;38:2177-2191.
    PubMed     Text format     Abstract available


  13. FEDOROVA O, Petukhov A, Daks A, Shuvalov O, et al
    Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
    Oncogene. 2019;38:2108-2122.
    PubMed     Text format     Abstract available


    February 2019
  14. SUN Y, Ding Y, Guo C, Liu C, et al
    alpha-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0762.
    PubMed     Text format     Abstract available


  15. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    PubMed     Text format     Abstract available


  16. BLOCK I, Muller C, Sdogati D, Pedersen H, et al
    CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.
    Oncogene. 2019 Feb 12. pii: 10.1038/s41388-019-0739.
    PubMed     Text format     Abstract available


  17. KANG MH, Jeong KJ, Kim WY, Lee HJ, et al
    Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Oncogene. 2019 Feb 4. pii: 10.1038/s41388-019-0721.
    PubMed     Text format     Abstract available


  18. HUANG X, Wang XN, Yuan XD, Wu WY, et al
    XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
    Oncogene. 2019;38:1448-1460.
    PubMed     Text format     Abstract available


  19. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    PubMed     Text format     Abstract available


    January 2019
  20. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
    PubMed     Text format     Abstract available


  21. ZHAO Y, Qiao S, Hou X, Tian H, et al
    Bioengineered tumor microenvironments with naked mole rats high-molecular-weight hyaluronan induces apoptosis in breast cancer cells.
    Oncogene. 2019 Jan 30. pii: 10.1038/s41388-019-0719.
    PubMed     Text format     Abstract available


  22. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
    TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
    PubMed     Text format     Abstract available


  23. CHOUCAIR A, Pham TH, Omarjee S, Jacquemetton J, et al
    The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0694.
    PubMed     Text format     Abstract available


  24. ZHOU XL, Zhu CY, Wu ZG, Guo X, et al
    The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0698.
    PubMed     Text format     Abstract available


  25. KOHLER M, Ehrenfeld S, Halbach S, Lauinger M, et al
    B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-018-0663.
    PubMed     Text format     Abstract available


  26. KIM I, Shin SH, Lee JE, Park JW, et al
    Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-019-0676.
    PubMed     Text format     Abstract available


  27. PANAGOPOULOU M, Karaglani M, Balgkouranidou I, Biziota E, et al
    Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0660.
    PubMed     Text format     Abstract available


  28. MANN J, Githaka JM, Buckland TW, Yang N, et al
    Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0673.
    PubMed     Text format     Abstract available


  29. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    PubMed     Text format     Abstract available


    December 2018
  30. MARUSIAK AA, Prelowska MK, Mehlich D, Lazniewski M, et al
    Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
    Oncogene. 2018 Dec 14. pii: 10.1038/s41388-018-0618.
    PubMed     Text format     Abstract available


  31. LAN Q, Peyvandi S, Duffey N, Huang YT, et al
    Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0624.
    PubMed     Text format     Abstract available


  32. PARONI G, Bolis M, Zanetti A, Ubezio P, et al
    HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0620.
    PubMed     Text format     Abstract available


  33. MA A, Tang M, Zhang L, Wang B, et al
    USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0590.
    PubMed     Text format     Abstract available


  34. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    PubMed     Text format     Abstract available


  35. KOLB R, Kluz P, Tan ZW, Borcherding N, et al
    Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.
    Oncogene. 2018 Dec 5. pii: 10.1038/s41388-018-0592.
    PubMed     Text format     Abstract available


    November 2018
  36. VARGAS G, Bouchet M, Bouazza L, Reboul P, et al
    ERRalpha promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0579.
    PubMed     Text format     Abstract available


  37. ZHAO H, Martin E, Matalkah F, Shah N, et al
    Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0574.
    PubMed     Text format     Abstract available


  38. TORRES-ADORNO AM, Vitrac H, Qi Y, Tan L, et al
    Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.
    Oncogene. 2018 Nov 20. pii: 10.1038/s41388-018-0569.
    PubMed     Text format     Abstract available


  39. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    PubMed     Text format     Abstract available


  40. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    PubMed     Text format     Abstract available


  41. ZHAO Z, Hao D, Wang L, Li J, et al
    CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0570.
    PubMed     Text format     Abstract available


    September 2018
  42. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
    C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
    PubMed     Text format     Abstract available


  43. ZHU J, Zhao C, Kharman-Biz A, Zhuang T, et al
    Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor alpha and modulates estrogen-stimulated breast cancer cell proliferation.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0502.
    PubMed     Text format     Abstract available


  44. ZHANG DD, Li Y, Xu Y, Kim J, et al
    Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.
    Oncogene. 2018 Sep 12. pii: 10.1038/s41388-018-0499.
    PubMed     Text format     Abstract available


  45. TRABOULSI T, El Ezzy M, Dumeaux V, Audemard E, et al
    Role of SUMOylation in differential ERalpha transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
    Oncogene. 2018 Sep 6. pii: 10.1038/s41388-018-0468.
    PubMed     Text format     Abstract available


  46. LIU Y, Long YH, Wang SQ, Zhang YY, et al
    JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.
    Oncogene. 2018 Sep 5. pii: 10.1038/s41388-018-0466.
    PubMed     Text format     Abstract available


  47. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    PubMed     Text format     Abstract available


  48. LI Y, Zhang H, Zhao Y, Wang C, et al
    A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERalpha-positive breast cancer cells.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0456.
    PubMed     Text format     Abstract available


    August 2018
  49. GUNTUKU L, Gangasani JK, Thummuri D, Borkar RM, et al
    IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0446.
    PubMed     Text format     Abstract available


  50. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    PubMed     Text format     Abstract available


  51. SARWAR M, Syed Khaja AS, Aleskandarany M, Karlsson R, et al
    The role of PIP5K1alpha/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1alpha inhibitor.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0438.
    PubMed     Text format     Abstract available


  52. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
    PubMed     Text format     Abstract available


  53. LORENZO-MARTIN LF, Citterio C, Menacho-Marquez M, Conde J, et al
    Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0433.
    PubMed     Text format     Abstract available


    July 2018
  54. CASTAGNINO A, Castro-Castro A, Irondelle M, Guichard A, et al
    Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function.
    Oncogene. 2018 Jul 31. pii: 10.1038/s41388-018-0422.
    PubMed     Text format     Abstract available


  55. HUANG X, Xie X, Liu P, Yang L, et al
    Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0410.
    PubMed     Text format     Abstract available


  56. ZHANG B, Lyu J, Liu Y, Wu C, et al
    BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0408.
    PubMed     Text format     Abstract available


  57. SHI L, Tang X, Qian M, Liu Z, et al
    A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
    PubMed     Text format     Abstract available


  58. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    PubMed     Text format     Abstract available


  59. YANG T, Ren C, Qiao P, Han X, et al
    PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2018 Jul 9. pii: 10.1038/s41388-018-0386.
    PubMed     Text format     Abstract available


  60. GUO X, Zhang Y, Mayakonda A, Madan V, et al
    ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0371.
    PubMed     Text format     Abstract available


  61. LI A, Chen P, Leng Y, Kang J, et al
    Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0379.
    PubMed     Text format     Abstract available


  62. DU WW, Yang W, Li X, Awan FM, et al
    A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0369.
    PubMed     Text format     Abstract available


  63. CUI YH, Kim H, Lee M, Yi JM, et al
    FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0372.
    PubMed     Text format     Abstract available


  64. GOLFMANN K, Meder L, Koker M, Volz C, et al
    Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.
    Oncogene. 2018 Jul 3. pii: 10.1038/s41388-018-0380.
    PubMed     Text format     Abstract available


    June 2018
  65. BROUGH R, Gulati A, Haider S, Kumar R, et al
    Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer.
    Oncogene. 2018 Jun 18. pii: 10.1038/s41388-018-0368.
    PubMed     Text format     Abstract available


  66. LEE S, Axelsen TV, Jessen N, Pedersen SF, et al
    Na(+),HCO3(-)-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.
    Oncogene. 2018 Jun 15. pii: 10.1038/s41388-018-0353.
    PubMed     Text format     Abstract available


    May 2018
  67. LU L, Dong J, Wang L, Xia Q, et al
    Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0340.
    PubMed     Text format     Abstract available


  68. SIRINIAN C, Papanastasiou AD, Schizas M, Spella M, et al
    RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-kappaB activation and EGFR signaling.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0324.
    PubMed     Text format     Abstract available


  69. TANG J, Li Y, Sang Y, Yu B, et al
    LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
    Oncogene. 2018 May 15. pii: 10.1038/s41388-018-0310.
    PubMed     Text format     Abstract available


  70. GALA K, Li Q, Sinha A, Razavi P, et al
    KMT2C mediates the estrogen dependence of breast cancer through regulation of ERalpha enhancer function.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0273.
    PubMed     Text format     Abstract available


  71. WANG PS, Chou CH, Lin CH, Yao YC, et al
    A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0293.
    PubMed     Text format     Abstract available


  72. ROGERS S, McCloy RA, Parker BL, Gallego-Ortega D, et al
    MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0295.
    PubMed     Text format     Abstract available


  73. PAREKH A, Das S, Parida S, Das CK, et al
    Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0272.
    PubMed     Text format     Abstract available


  74. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    PubMed     Text format     Abstract available


  75. AHIRWAR DK, Nasser MW, Ouseph MM, Elbaz M, et al
    Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0263.
    PubMed     Text format     Abstract available


  76. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    PubMed     Text format     Abstract available


  77. PAVAN S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, et al
    A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0270.
    PubMed     Text format     Abstract available


    April 2018
  78. CHANG JW, Kuo WH, Lin CM, Chen WL, et al
    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0253.
    PubMed     Text format     Abstract available


  79. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    PubMed     Text format     Abstract available


  80. BLANCHETTE-FARRA N, Kita D, Konstorum A, Tesfay L, et al
    Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
    Oncogene. 2018 Apr 26. pii: 10.1038/s41388-018-0243.
    PubMed     Text format     Abstract available


  81. SUN L, Xu X, Chen Y, Zhou Y, et al
    Rab34 regulates adhesion, migration, and invasion of breast cancer cells.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0202.
    PubMed     Text format     Abstract available


    March 2018
  82. ZHANG Z, Lin G, Yan Y, Li X, et al
    Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0221.
    PubMed     Text format     Abstract available


  83. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    PubMed     Text format     Abstract available


  84. WANG S, Zou Z, Luo X, Mi Y, et al
    LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0193.
    PubMed     Text format     Abstract available


  85. STEBBING J, Shah K, Lit LC, Gagliano T, et al
    LMTK3 confers chemo-resistance in breast cancer.
    Oncogene. 2018 Mar 15. pii: 10.1038/s41388-018-0197.
    PubMed     Text format     Abstract available


  86. KIM S, Lee E, Jung J, Lee JW, et al
    microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
    Oncogene. 2018 Mar 12. pii: 10.1038/s41388-018-0124.
    PubMed     Text format     Abstract available


    February 2018
  87. HE H, Sinha I, Fan R, Haldosen LA, et al
    c-Jun/AP-1 overexpression reprograms ERalpha signaling related to tamoxifen response in ERalpha-positive breast cancer.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0165.
    PubMed     Text format     Abstract available


  88. SIRKISOON SR, Carpenter RL, Rimkus T, Anderson A, et al
    Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0132.
    PubMed     Text format     Abstract available


  89. SAATCI O, Borgoni S, Akbulut O, Durmus S, et al
    Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
    Oncogene. 2018 Feb 2. pii: 10.1038/s41388-017-0108.
    PubMed     Text format     Abstract available


    January 2018
  90. IRELAND L, Santos A, Campbell F, Figueiredo C, et al
    Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0115.
    PubMed     Text format     Abstract available


  91. BROWNE AL, Charmsaz S, Vareslija D, Fagan A, et al
    Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0042.
    PubMed     Text format     Abstract available


  92. LIANG H, Xiao J, Zhou Z, Wu J, et al
    Hypoxia induces miR-153 through the IRE1alpha-XBP1 pathway to fine tune the HIF1alpha/VEGFA axis in breast cancer angiogenesis.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0089.
    PubMed     Text format     Abstract available


  93. LIAO Y, Xia X, Liu N, Cai J, et al
    Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0069.
    PubMed     Text format     Abstract available


  94. ZHANG Y, Wester L, He J, Geiger T, et al
    IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0027.
    PubMed     Text format     Abstract available


  95. NAVANEETHAKRISHNAN S, Rosales JL, Lee KY
    Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0103.
    PubMed     Text format     Abstract available


  96. LEE GH, Yoo KC, An Y, Lee HJ, et al
    FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0114.
    PubMed     Text format     Abstract available


  97. IKINK GJ, Boer M, Bakker ERM, Vendel-Zwaagstra A, et al
    Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
    Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0031.
    PubMed     Text format     Abstract available


  98. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    PubMed     Text format     Abstract available


  99. MORATH I, Jung C, Leveque R, Linfeng C, et al
    Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0030.
    PubMed     Text format     Abstract available


    December 2017
  100. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  101. HOWLEY BV, Link LA, Grelet S, El-Sabban M, et al
    A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0023.
    PubMed     Text format     Abstract available


  102. HAN B, Zhou B, Qu Y, Gao B, et al
    FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0021.
    PubMed     Text format     Abstract available


  103. LUSTIG LC, Dingar D, Tu WB, Lourenco C, et al
    Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
    Oncogene. 2017;36:6830-6837.
    PubMed     Text format     Abstract available


    November 2017
  104. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    October 2017
  105. LANGER EM, Kendsersky ND, Daniel CJ, Kuziel GM, et al
    ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  106. KNOPFOVA L, Biglieri E, Volodko N, Masarik M, et al
    Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  107. LUCANUS AJ, Yip GW
    Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  108. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  109. XIA L, Xiao X, Liu WL, Song Y, et al
    Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFbeta signaling.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  110. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  111. ROWSON-HODEL AR, Wald JH, Hatakeyama J, O'Neal WK, et al
    Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: